Cargando…
Can the HIV-1 splicing machinery be targeted for drug discovery?
HIV-1 is able to express multiple protein types and isoforms from a single 9 kb mRNA transcript. These proteins are also expressed at particular stages of viral development, and this is achieved through the control of alternative splicing and the export of these transcripts from the nucleus. The nuc...
Autores principales: | Dlamini, Zodwa, Hull, Rodney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354533/ https://www.ncbi.nlm.nih.gov/pubmed/28331370 http://dx.doi.org/10.2147/HIV.S120576 |
Ejemplares similares
-
The role played by alternative splicing in antigenic variability in human endo-parasites
por: Hull, Rodney, et al.
Publicado: (2014) -
Human Immunodeficiency Virus-1 (HIV-1)-Mediated Apoptosis: New Therapeutic Targets
por: Mbita, Zukile, et al.
Publicado: (2014) -
Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers
por: Mthembu, Nonkululeko N, et al.
Publicado: (2017) -
Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases
por: Dlamini, Zodwa, et al.
Publicado: (2015) -
Regulation of alternative splicing in obesity-induced hypertension
por: Dlamini, Zodwa, et al.
Publicado: (2019)